PSMA for prostate cancer
- Why Targeting PSMA Is a Game Changer in the Management of Prostate Cancer
National Institutes of Health PubMed - [177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer
National Institutes of Health PubMed - For Advanced Prostate Cancer, Radiopharmaceutical Improves Survival
National Cancer Institute
Thyroid treatment
- Radioiodine I-131 for the Therapy of Graves’ Disease
National Institutes of Health PubMed - About Thyroid Cancer
American Cancer Society - Radioactive Iodine for Thyroid Malignancies
National Institutes of Health PubMed
PRRT for neuroendocrine tumor
- Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward
National Institutes of Health PubMed - Peptide receptor radionuclide therapy (PRRT)
Cancer Research UK